AXA Framlington UK Equity Income Z £ Inc (FUND:B8HHY29) - Fund price


Fund Report

AXA Framlington UK Equity Income Fund Z GBP Inc

Key Stats
Morningstar® CategoryUK Equity Income
Manager Name-
Inception Date10/09/2012
NAV 20/09/2019GBX 128.50
Day Change0.39%
12 Month Yield4.11%
ISINGB00B8HHY295
Dividend FrequencyQuarterly
Net Assets (mil) 31/08/201975.30 GBP
Wrapper AvailabilityAll
Our Minimum Initial Investment1.00 Share
Pricing FrequencyDaily
Dealing Cut off Time11:00:00
Regular InvestmentYes
Actual Initial Charge0.00%
Exit Charge-
Custody ChargeYes
Ongoing Cost0.85%
AMC0.75%
Fund Rebate-

Morningstar Rating™

StarRatingValueLabel_3

Morningstar Sustainability Rating

Above Average

Above Average


Sustainability Rating as of 31/07/2019

Benchmarks

Fund Benchmark

FTSE 350 TR GBP

Morningstar® Benchmark

FTSE All Share TR GBP

Growth Of 10,000 (GBP) 31/08/2019

How has this security performed
201420152016201720182019
Fund3.695.489.928.64-11.4413.36
Category3.896.338.7610.73-10.567.92
Benchmark1.180.9816.7513.10-9.4711.12
  • Fund: AXA Framlington UK Equity Income Fund Z GBP Inc
  • Category: UK Equity Income
  • Benchmark: FTSE All Share TR GBP
Trailing Returns % (GBP) 20/09/2019
FundCatBmark
YTD15.7111.6713.85
3 Years Annualised4.864.296.88
5 Years Annualised4.725.066.03
10 Years Annualised7.118.488.11

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Investment Objective

The aim of this Fund is to produce higher than average income with long-term growth of income and capital. The Manager also intends to achieve a yield of distributable income in excess of 100% of the FTSE All Share yield at the Fund’s year end on a rolling 3 year basis, and in excess of 90% on an annual basis.

Portfolio Profile31/08/2019

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
GlaxoSmithKline PLC Healthcare7.43
DecreaseAstraZeneca PLC Healthcare6.90
RELX PLC Consumer Cyclical5.94
Unilever PLC Consumer Defensive5.89
Royal Dutch Shell PLC B Energy5.45
Asset Allocation %
LongShortNet
Stocks98.430.0098.43
Bonds0.000.000.00
Cash2.060.471.59
Other0.060.09-0.02
Top Stock Regions
Region%
United Kingdom95.24
United States1.89
Eurozone1.65
Europe - Emerging0.84
Australasia0.11
Top Stock Sectors
Stock Sector%
Financial Services23.68
Healthcare17.75
Consumer Cyclical16.04
Consumer Defensive14.73
Energy10.51
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.